Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects

Hematological Oncology

Volumn 20, Issue 1, 2002, Pages 17-32

  Almawi, Wassim Y ^a   Maroun, M ^b   Jaoude, Abou ^c   Li, Xian C ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; CYTOKINE RECEPTOR; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DNA RESPONSIVE ELEMENT; DRUG ACTIVITY; DRUG INDICATION; GENE EXPRESSION; GRAFT REJECTION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; GRAFT REJECTION; HEMATOLOGIC NEOPLASMS; HUMANS; TRANSCRIPTION, GENETIC;

EID: 0036217620     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.684     Document Type: Review

References (160)

1. Trends in the use of glucocorticoids in renal transplantation
2. Regulation of cytokine and cytokine receptor expression by glucocorticoids
3. Glucocorticoids therapy for immune-mediated diseases: Basic and clinical correlates
4. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4
5. Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis
6. A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma
7. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
8. Time course of inflammatory and remodeling events in a murine model of asthma: Effect of steroid treatment
9. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids
10. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells
11. Post-transcriptional mechanisms of glucocorticoid anti-proliferative effects. Glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells
12. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through the IL-2 receptor
13. Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes
14. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone
15. Glucocorticoids inhibit proliferation and adhesion of the IL-3-dependent mast cell line, MC/9, to NIH/3T3 fibroblasts, with an accompanying decrease in IL-3 receptor expression
16. The interleukin-I type 2 receptor gene displays immediate gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes
17. Immunobiology and immunopharmacology of organ allograft rejection
18. The three dimensional structure of peptide-MHC complexes
19. Complex complexes: Signaling at the TCR
20. The balance of protein kinase C and calcium signaling directs T cell subset development
21. Opening a window on thymic positive selection: Developmental changes in the influence of cosignaling by integrins and CD28 on selection events induced by TCR engagement
22. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells
23. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes
24. CD4 augments the response of a T cell to agonist but not to antagonist ligands
25. The T cell receptor as a multicomponent signaling machine: CD4/CD8 coreceptors and CD45 in T cell activation
26. Antigen-specific regulation of T cell-mediated cytokine production
27. T cell antigen receptor signal transduction pathways
28. Crosstalk among multiple signal-activated phospholipases
29. Protein modules and signalling networks
30. The regulation and function of p21ras during T-cell activation and growth
31. Identification of calcineurin as a key signaling enzyme in T lymphocyte activation
32. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A
33. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats
34. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation
35. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells
36. Duration of TCR stimulation determines co-stimulatory requirements of T cells
37. The immunosuppressive FK506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer
38. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection
39. Immunosuppressive drugs acting through inhibition of cytokine expression
40. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: Clinical, biomedical, and analytical aspects
41. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
42. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms
43. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
44. T cell antigen receptor activation pathways: The tyrosine kinase connection
45. Glucocorticoids inhibit transcription and post-transcriptional expression of interleukin-1
46. Inhibition by glucocorticoids of the formation of interleukin-1α interleukin-1β, and interleukin-6: Mediation by decreased mRNA stability
47. Abrogation of glucocorticoisteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma
48. Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes
49. Glucocorticoids regulation of lymphokine production by murine T lymphocytes
50. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter
51. Glucocorticoids suppress autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression
52. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects
53. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α
54. Glucocorticoids downregulate gene expression of GM-CSF-NAP-1/IL-8, and IL-6, but not M-CSF, in human fibroblasts
55. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
56. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes
57. Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone
58. Immunosuppression by glucocorticoids: Inhibition of production of multiple lymphokines by in vivo administration of dexamethasone
59. Dexamethasone inhibits IL-1 and TNF activity in human lung fibroblasts without affecting IL-1 or TNF receptors
60. Selective inhibition of NF-κB activation and TNF-α production in macrophages by red blood cell-mediated delivery of dexamethasone
61. Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor
62. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes
63. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol ester-induced monocytic differentiation by dexamethasone and cyclosporin A potential involvement of a destabilizing protein
64. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells
65. Dexamethasone inhibits interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription
66. Partial mediation of glucocorticoid anti-proliferative effect by lipocortins
67. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids
68. IL-2 rescues antigen-specific T cells from radiation- or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2
69. Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds
70. DNA binding specificity of steroid receptors
71. Molecular genetics of corticosteroid action
72. Effect of corticosteroids, cyclosporin A, and methotrexate on cytokine release from monocytes and T cell subsets
73. Mode of action of the glucocorticosteroids as immunosuppressive agents
74. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
75. Cytokines and their receptors: Molecular mechanism of interleukin-6 gene repression by glucocorticoids
76. Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression
77. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
78. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells
79. Homodimer formation is rate-limiting for high-affinity DNA binding by glucocorticoid receptor
80. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter
81. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor
82. A functional glucocorticoid-responsive unit composed of two overlapping inactive receptor-binding sites: Evidence for formation of a receptor tetramer
83. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
84. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements
85. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter
86. Negative regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT
87. Glucocorticoid induction of CRE-binding protein isoform mRNA in rat C6 glioma cells
88. Transcription factor interactions: Selecters of positive or negative regulation from a single DNA element
89. Identification of two distinct nuclear factors with DNA binding activity within the glucocorticoid regulatory region of the rat alpha-1-acid glycoprotein promoter
90. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
91. Induction of IκBα mRNA expression in the brain by glucocorticoids: A negative feedback mechanism for immune-to-brain signaling
92. Role of transcriptional activation IκBα in mediation of immunosuppression by glucocorticoids
93. Induction of cyclooxygenase-2 by platelet-derived growth factor (PDGF) and its inhibition by dexamethasone are independent of NF-κB/IκB transcription factors
94. Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-κB
95. Transrepression of NF-kappaB is not required for glucocorticoid protection of TNF-α-induced apoptosis on fibroblasts
96. Accessory function of interleukin-1 and interleukin-6: Preferential co-stimulation of T4 positive lymphocytes
97. Glucocorticoids selectively inhibit the transcription of the interleukin 1α gene and decrease the stability of interleukin 1α mRNA
98. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor
99. Modulation of mycoplasma arthritidis derived super-antigen-induced cytokine gene expression by dexamethasone and interleukin-4
100. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoids in human T lymphoblastic leukemic cells
101. Inhibition of interleukin-5 gene expression by dexamethasone
102. T cell receptor-independent immunosuppression induced by dexamethasone in murine T helper cells
103. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and beta subunit expression by human T cells
104. Interleukin-2 induces γ-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activation
105. Functional diversity of helper T lymphocytes
106. Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties
107. Biology of human Th1 and Th2 cells
108. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production
109. Regulation of T helper cell cytokine expression: Functional dichotomy of antigen-presenting cells
110. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages
111. H cells
112. Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice
113. CD28 costimulation promotes the production of Th2 cytokines
114. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells
115. Th1 and Th2 subsets: Paradigms lost?
116. Manipulation of cytokine networks in transplantation. False hope or realistic opportunity for tolerance?
117. Interleukin 4 suppresses interleukin 2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement
118. Clonal proliferation of type 2 helper T cells in a man with the hyper-eosinophilic syndrome
119. Lymphokine production by human T cells in disease states
120. IL-4 directs the development of Th2-like helper functions
121. Subsets of CD4+ T cells and their role in the induction and prevention of autoimmunity
122. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity
123. Cytokine mRNA expression in tolerant heat allografts after immunosuppression with cyclosporin, sirolimus or brequinar
124. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone
125. Different modulation by histamine of IL-4 and interferongamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones
126. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro
127. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism
128. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4
129. Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids
130. Human Th1 cells preferentially induce interleukin (IL)-1 beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
131. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes
132. The Th1 and Th2 cytokines IFN-γ and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: Involvement of IL-1
133. Coordinated antiinflammatory effects of interleukin 4: Interleukin 4 suppresses interleukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist
134. Cross-regulation between T helper cell (Th) 1 and Th2: Inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1
135. IL-1 activates two separate signal transduction pathways in T helper type II cells
136. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells
137. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis
138. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response
139. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
140. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12
141. RU-486 blocks differentially suppressive effect of stress on in vivo anti-KLH immunoglobulin response
142. Limiting dilution analysis of proliferation and helper T cells in the in vivo immune response to KLH: Depression of helper T class at moderately increased frequencies
143. Hydrocortisone inhibition of human interleukin-4
144. Glucocorticosteroids affect functions of airway- and blood-derived human T cell clones, favoring the Th1 profile through two mechanisms
145. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes
146. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells
147. Mediation of glucocorticoid receptor function by transforming growth factor beta 1 expression in human PC-3 prostate cancer cells
148. Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. Transforming growth factor-beta 3
149. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells
150. Actions and interactions of glucocorticoids and transforming growth factor beta on two related human myeloma cell lines
151. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras
152. Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myeloma-monocytic HL60 macrophage-like cells
153. Differential regulation of the expression of transforming growth factor-beta 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells
154. Effect of dexamethasone on the expression of transforming growth factor-β in mouse embryonic palatal mesenchymal cells
155. Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 and in embryo fibroblasts
156. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts
157. Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3
158. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells
159. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro
160. Induction of metallothionein gene expression by epidermal growth factor and its inhibition by transforming growth factor-beta and dexamethasone in rat hepatocytes